Total Payments
$6,796
2024 Payments
$1,525
Companies
43
Transactions
345
Medicare Patients
2,277
Medicare Billing
$246,526
Payment Breakdown by Category
Food & Beverage$6,621 (97.4%)
Education$153.87 (2.3%)
Other$21.15 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,621 | 332 | 97.4% |
| Education | $153.87 | 12 | 2.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21.15 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $1,065 | 69 | $0 (2024) |
| SK Life Science, Inc. | $791.32 | 14 | $0 (2024) |
| Ceribell, Inc. | $667.83 | 4 | $0 (2024) |
| ABBVIE INC. | $557.34 | 26 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $503.67 | 98 | $0 (2020) |
| GENZYME CORPORATION | $366.35 | 6 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $362.00 | 13 | $0 (2023) |
| Biogen, Inc. | $267.04 | 9 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $259.30 | 10 | $0 (2024) |
| UCB, Inc. | $256.12 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,525 | 38 | Ceribell, Inc. ($356.88) |
| 2023 | $1,427 | 58 | ACADIA Pharmaceuticals Inc ($347.26) |
| 2022 | $644.40 | 20 | SK Life Science, Inc. ($260.58) |
| 2021 | $837.84 | 29 | Amneal Pharmaceuticals LLC ($225.62) |
| 2020 | $398.40 | 41 | Amneal Pharmaceuticals LLC ($120.27) |
| 2019 | $1,070 | 101 | Supernus Pharmaceuticals, Inc. ($211.66) |
| 2018 | $559.04 | 41 | Supernus Pharmaceuticals, Inc. ($134.57) |
| 2017 | $334.20 | 17 | Genentech USA, Inc. ($88.37) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $131.81 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $117.11 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $9.08 | General |
| 09/18/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $91.80 | General |
| Category: Neurology | ||||||
| 09/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $94.57 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $106.90 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROLOGY | ||||||
| 08/08/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Adenosine A2A Receptors | ||||||
| 08/07/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.74 | General |
| 07/31/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: NEUROLOGY | ||||||
| 07/10/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROLOGY | ||||||
| 07/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Neurology | ||||||
| 07/09/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROLOGY | ||||||
| 06/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/21/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $3.46 | General |
| 06/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROLOGY | ||||||
| 06/19/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Neurology | ||||||
| 06/18/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Immune | ||||||
| 06/17/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $207.07 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 529 | 685 | $148,690 | $60,178 |
| 2022 | 9 | 518 | 671 | $140,057 | $57,521 |
| 2021 | 10 | 624 | 773 | $153,490 | $66,406 |
| 2020 | 10 | 606 | 745 | $151,065 | $62,421 |
Total Patients
2,277
Total Services
2,874
Medicare Billing
$246,526
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 129 | 131 | $46,243 | $16,847 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 196 | $24,892 | $11,871 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 119 | $21,420 | $9,970 | 46.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 62 | $11,284 | $5,554 | 49.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 13 | 25 | $11,375 | $3,909 | 34.4% |
| 95723 | Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | Facility | 2023 | 19 | 19 | $10,925 | $2,977 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,052 | $2,786 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $5,040 | $2,628 | 52.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 46 | 46 | $5,796 | $1,758 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $3,915 | $1,496 | 38.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $748.00 | $383.20 | 51.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 127 | 130 | $45,890 | $19,044 | 41.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 117 | 203 | $25,781 | $10,851 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 107 | $18,917 | $8,579 | 45.4% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 15 | 31 | $14,105 | $4,930 | 35.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 50 | $9,100 | $3,929 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $9,336 | $3,619 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 21 | $5,004 | $2,566 | 51.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 61 | 62 | $7,812 | $2,477 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 32 | $4,112 | $1,526 | 37.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 152 | 158 | $55,758 | $23,624 | 42.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 118 | 225 | $28,575 | $12,499 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 110 | $19,030 | $9,047 | 47.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 69 | 69 | $18,254 | $7,495 | 41.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 48 | $8,736 | $3,848 | 44.0% |
About Dr. Ty Brown, MD
Dr. Ty Brown, MD is a Clinical Neurophysiology healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205037470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ty Brown, MD has received a total of $6,796 in payments from pharmaceutical and medical device companies, with $1,525 received in 2024. These payments were reported across 345 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,621).
As a Medicare-enrolled provider, Brown has provided services to 2,277 Medicare beneficiaries, totaling 2,874 services with total Medicare billing of $246,526. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Location Crestview Hills, KY
- Active Since 05/29/2007
- Last Updated 09/24/2018
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1205037470
Products in Payments
- RYTARY (Drug) $741.18
- XCOPRI (Drug) $696.99
- NUPLAZID (Drug) $362.00
- POCKET EEG DEVICE (Device) $356.88
- QULIPTA (Drug) $351.74
- Ceribell Rapid Response EEG (Device) $310.95
- OXTELLAR XR (Drug) $293.74
- EPIDIOLEX (Drug) $247.38
- APTIOM (Drug) $225.14
- Briviact (Drug) $217.87
- TROKENDI XR (Drug) $209.93
- NURTEC ODT (Drug) $161.90
- AUBAGIO (Drug) $137.47
- CREXONT (Drug) $134.92
- Aimovig (Biological) $126.19
- DISEASE STATE (Drug) $117.42
- TYSABRI (Biological) $116.50
- UBRELVY (Drug) $109.52
- VUMERITY (Drug) $109.48
- LEMTRADA (Drug) $105.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.